210 related articles for article (PubMed ID: 24697566)
1. Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.
Lee YH; Bae SC; Song GG
Genet Test Mol Biomarkers; 2014 May; 18(5):341-8. PubMed ID: 24697566
[TBL] [Abstract][Full Text] [Related]
2. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
Xie R; Tang S; Yang Y
J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
4. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: a meta-analysis.
Wang J; Guo X; Wu P; Song J; Ye C; Yu S; Zhang J; Dong W
Gene; 2013 Oct; 528(2):328-34. PubMed ID: 23891820
[TBL] [Abstract][Full Text] [Related]
5. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
[TBL] [Abstract][Full Text] [Related]
6. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.
Su Y; Liu Z; Yang L; Li Y; Jiang S; Yao H; Du G
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):894-904. PubMed ID: 32505733
[TBL] [Abstract][Full Text] [Related]
7. COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
Lee YH; Song GG
Neurol Sci; 2014 May; 35(5):643-51. PubMed ID: 24477323
[TBL] [Abstract][Full Text] [Related]
8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
[TBL] [Abstract][Full Text] [Related]
10. Association between PPAR-γ2 Pro12Ala polymorphism and obesity: a meta-analysis.
Yao YS; Li J; Jin YL; Chen Y; He LP
Mol Biol Rep; 2015 Jun; 42(6):1029-38. PubMed ID: 25502405
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
[TBL] [Abstract][Full Text] [Related]
12. PRO12ALA POLYMORPHISM ASSOCIATION OF PPAR-γ GENE WITH BIOCHEMICAL PARAMETERS OF THE BLOOD IN PATIENTS WITH CHRONIC DIFFUSE LIVER DISEASES.
Prysyazhnyuk V
Georgian Med News; 2015 Sep; (246):35-40. PubMed ID: 26355313
[TBL] [Abstract][Full Text] [Related]
13. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.
Rey JW; Noetel A; Hardt A; Canbay A; Alakus H; Zur Hausen A; Dienes HP; Drebber U; Odenthal M
World J Gastroenterol; 2010 Dec; 16(46):5830-7. PubMed ID: 21155004
[TBL] [Abstract][Full Text] [Related]
14. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
Zhou TB; Guo XF; Yin SS
J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
[TBL] [Abstract][Full Text] [Related]
16. Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis.
Lee YH; Bae SC
Clin Rheumatol; 2016 Apr; 35(4):961-71. PubMed ID: 26474773
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
[TBL] [Abstract][Full Text] [Related]
18. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
Bhatt SP; Nigam P; Misra A; Guleria R; Luthra K; Pandey RM; Pasha MA
Gene; 2013 Jan; 512(1):143-7. PubMed ID: 23031808
[TBL] [Abstract][Full Text] [Related]
19. Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.
Li L; Cheng LX; Nsenga R; He MA; Wu TC
Clin Cardiol; 2006 Jul; 29(7):300-4. PubMed ID: 16881538
[TBL] [Abstract][Full Text] [Related]
20. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
Wei Z; Han G; Bai X
Med Sci Monit; 2015 Jun; 21():1611-6. PubMed ID: 26049557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
